These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 32295509)
1. Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial. Ntaios G; Pearce LA; Veltkamp R; Sharma M; Kasner SE; Korompoki E; Milionis H; Mundl H; Berkowitz SD; Connolly SJ; Hart RG; Stroke; 2020 Jun; 51(6):1797-1804. PubMed ID: 32295509 [TBL] [Abstract][Full Text] [Related]
2. Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial. Ntaios G; Pearce LA; Meseguer E; Endres M; Amarenco P; Ozturk S; Lang W; Bornstein NM; Molina CA; Pagola J; Mundl H; Berkowitz SD; Liu YY; Sen S; Connolly SJ; Hart RG Stroke; 2019 Nov; 50(11):3184-3190. PubMed ID: 31526123 [TBL] [Abstract][Full Text] [Related]
3. High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source. Scheitz JF; Pare G; Pearce LA; Mundl H; Peacock WF; Czlonkowska A; Sharma M; Nolte CH; Shoamanesh A; Berkowitz SD; Krahn T; Endres M; Stroke; 2020 Aug; 51(8):2386-2394. PubMed ID: 32640945 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis. Ntaios G; Swaminathan B; Berkowitz SD; Gagliardi RJ; Lang W; Siegler JE; Lavados P; Mundl H; Bornstein N; Meseguer E; Amarenco P; Cucchiara B; Camps-Renom P; Makaritsis K; Korompoki E; Papavasileiou V; Marti-Fabregas J; Milionis H; Vemmos K; Connolly SJ; Hart RG; Stroke; 2019 Sep; 50(9):2477-2485. PubMed ID: 31401971 [TBL] [Abstract][Full Text] [Related]
5. Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin: A Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical Trial. Merkler AE; Pearce LA; Kasner SE; Shoamanesh A; Birnbaum LA; Kamel H; Sheth KN; Sharma R JAMA Neurol; 2021 Dec; 78(12):1454-1460. PubMed ID: 34694346 [TBL] [Abstract][Full Text] [Related]
6. Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy. Ameriso SF; Amarenco P; Pearce LA; Perera KS; Ntaios G; Lang W; Bereczki D; Uchiyama S; Kasner SE; Yoon BW; Lavados P; Firstenfeld A; Mikulik R; Povedano GP; Ferrari J; Mundl H; Berkowitz SD; Connolly SJ; Hart RG J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104936. PubMed ID: 32689594 [TBL] [Abstract][Full Text] [Related]
7. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial. Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ; J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218 [TBL] [Abstract][Full Text] [Related]
8. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial. Shoamanesh A; Hart RG; Connolly SJ; Kasner SE; Smith EE; Martí-Fàbregas J; Liu YY; Uchiyama S; Mikulik R; Veltkamp R; O'Donnell MJ; Ntaios G; Muir KW; Field TS; Santo GC; Olavarria V; Mundl H; Lutsep H; Berkowitz SD; Sharma M JAMA Neurol; 2021 Jan; 78(1):11-20. PubMed ID: 33074284 [TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Kasner SE; Swaminathan B; Lavados P; Sharma M; Muir K; Veltkamp R; Ameriso SF; Endres M; Lutsep H; Messé SR; Spence JD; Nedeltechev K; Perera K; Santo G; Olavarria V; Lindgren A; Bangdiwala S; Shoamanesh A; Berkowitz SD; Mundl H; Connolly SJ; Hart RG; Lancet Neurol; 2018 Dec; 17(12):1053-1060. PubMed ID: 30274772 [TBL] [Abstract][Full Text] [Related]